Sodium-glucose cotransporter-2 inhibitors: heart failure and renal protection indications
MT El Hussein, N Bell - The Journal for Nurse Practitioners, 2022 - Elsevier
Abstract Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) are a class of oral
antihyperglycemic drugs recently added to clinical practice guidelines to manage type 2 …
antihyperglycemic drugs recently added to clinical practice guidelines to manage type 2 …
Decompensated heart failure: a reconceptualization in the light of updated consensus statement of the European Society of Cardiology
VN Larina, VA Kokorin, VG Larin… - Russian Journal of …, 2023 - russjcardiol.elpub.ru
The article presents a brief analytical review of the European Society of Cardiology
consensus statement on the definition and clinical features of heart failure (HF) with a …
consensus statement on the definition and clinical features of heart failure (HF) with a …
Prescrição de inibidores do cotransportador de sódio-glicose 2 em portadores de insuficiência cardíaca: uma revisão de literatura
HJE Guimarães, VRR da Silva… - Revista Eletrônica …, 2022 - acervomais.com.br
Objetivo: Analisar os benefícios da prescrição de inibidores do cotransportador de sódio-
glicose 2 em portadores de insuficiência cardíaca. Avaliando, assim, a redução de eventos …
glicose 2 em portadores de insuficiência cardíaca. Avaliando, assim, a redução de eventos …
Myokardiale Deformitätsparameter und deren Verlauf bei chronischer Herzinsuffizienz-Eine Untersuchung mittels kardialer Magnetresonanztomographie
P Gann - 2024 - oparu.uni-ulm.de
Hintergrund: Um die Diagnostik und Therapie der chronischen Herzinsuffizienz
weiterzuentwickeln muss die aktuelle Versorgungsrealität der Patienten untersucht werden …
weiterzuentwickeln muss die aktuelle Versorgungsrealität der Patienten untersucht werden …
[HTML][HTML] Management of Heart Failure with Reduced Ejection Fraction Globally and in Lebanon: Where Do SGLT-2is Stand?
H Skouri, TA Massih, S Chaaban, E Chammas… - World Journal of …, 2023 - scirp.org
Heart failure (HF) is a clinical syndrome due to structural and/or functional cardiac
anomalies, accompanied by elevated natriuretic peptide levels and/or cardiogenic …
anomalies, accompanied by elevated natriuretic peptide levels and/or cardiogenic …
[HTML][HTML] The 'diamond'approach to personalized drug treatment of heart failure with reduced ejection fraction
H Gan, H Tang, Y Huang, D Wang, P Pu… - Reviews in …, 2021 - imrpress.com
Heart failure (HF) is a complex clinical syndrome with symptoms and signs due to cardiac
dysfunction, leading to high hospitalization and morbidity. HF treatment has rapidly …
dysfunction, leading to high hospitalization and morbidity. HF treatment has rapidly …
Puesta al día sobre el empleo de dapagliflozina en insuficiencia cardiaca con fracción de eyección reducida
A pesar de los avances en el tratamiento de la insuficiencia cardiaca (IC) con fracción de
eyección reducida (IC-FEr), las tasas de mortalidad e ingresos hospitalarios continúan …
eyección reducida (IC-FEr), las tasas de mortalidad e ingresos hospitalarios continúan …
Worsening heart failure and current management strategies with a focus on soluble guanylate cyclase stimulators
Worsening heart failure (WHF) represents a critical point in the disease trajectory of heart
failure (HF) patients and significantly affects prognosis negatively. WHF is understood to be …
failure (HF) patients and significantly affects prognosis negatively. WHF is understood to be …
Dapagliflozin improves endothelial integrity and hemodynamics in endotoxin treated mice through an apolipoprotein M dependent pathway
Rationale Sodium-glucose co-transporter inhibitors (SGLT2i) are under active clinical
investigation in patients with acute inflammatory conditions, based on their clinical cardio …
investigation in patients with acute inflammatory conditions, based on their clinical cardio …